Perth-based biotechnology comapny pSivida Ltd has signed a $33.7 million agreement with an unnamed investment fund to finance development of the company's diabetic macular edema treatment.
10/11/2006 - 08:16
pSivida signs $33.7m MOU to fund eye disease treatment
10/11/2006 - 08:16
